Asterias Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AST and buy or sell other stocks, ETFs, and their options commission-free!About AST
Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer.
CEOBrian M. Culley, MBA
CEOBrian M. Culley, MBA
Employees—
Employees—
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2012
Founded2012
Employees—
Employees—
AST Key Statistics
Market cap92.97M
Market cap92.97M
Price-Earnings ratio-3.54
Price-Earnings ratio-3.54
Dividend yield—
Dividend yield—
Average volume81.23K
Average volume81.23K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.75
52 Week high$3.75
52 Week low$1.20
52 Week low$1.20